Clinical OMICS

NOV-DEC 2017

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 20 of 47

Thursday November 30, 2017 8: 00 am PT 11:00 am ET 17:00 CET DURATION: 60 minutes COST: Complimentary Speaker Quantitative, Reproducible, Standardized, and Scalable — Needs for Translational Proteomics The transition from discovery proteomics to translational research in the pipeline of precision medicine means that we are no longer measured by the number of protein identifications, highest sensitivity or best coverage, but success criteria focused on quantitation, reproducibility, standardization, scalability, access to curated references, and rigorous statistics. These studies require implementation of highly robust analytical platforms to deliver accurate and reproducible peptide/protein quantitation along with high throughput. Ultimately, verification of protein biomarkers requires confident quantitation of low-level proteins in large-cohort studies in a standardized and precise manner. In this Clinical Omics webinar, we will discuss several new technology developments and optimization of each component in the translational proteomics workflow: sample preparation, separations, mass spectrometry, and data analysis. A particular emphasis will be placed on integrating these to enable end- to-end, complete, standardized solutions for the rigors of quantitative proteomics focusing on label-free precursor-based quantitation. A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert presenter. Free Registration! You Will Learn • Success Criteria for quantitative high-throughput proteomics • Current quantitative proteomics workflow pain points • A new robust DDA+ and HR-DIA label-free quantitation approaches with Thermo Scientific™ high-resolution accurate-mass (HRAM) Orbitrap MS • About the development of quantitative, standardized, reproducible, and precise proteomic workflows For Research Use Only. Not for use in diagnostic procedures. Aaron Gajadhar, Ph.D. Strategic Marketing Specialist – Quantitative Proteomics Thermo Fisher Scientific Produced with support from Webinars

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - NOV-DEC 2017